CSI Market
Sign In | Register

Orthofix Medical Inc (OFIX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access OFIX quarterly Cash Flow →
Examining cash flow movements between Orthofix Medical Inc and Dec 31 2021 reveals how Dec 31 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-92.19
Depreciation & amortization47.30
Amortization of Other Assets30.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-1.14
Provision For Loan Losses Expensed2.26
Increase (Decrease) in Inventories10.75
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-1.14
Share-based Compensation28.69
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities-2.91
Debt Refinancing Charge-
Gain Loss On Derivative Instruments Net Pretax-
Depreciation Depletion And Amortization Including Portion From Discontinued Operations-
Amortization Of Exclusivity Agreements-
Goodwill And Intangible Asset Impairment-
Employee Service Share Based Compensation Tax Benefit From Compensation Expense-
Amortization Of Debt Costs And Other Assets-
Gain On Valuation Of Equity Securities-
Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings-
Gain Loss On Valuation Of Equity Securities-
Amortization Of Lease Assets Debt Costs And Other Assets5.93
Inventory Reserve Expenses30.83
Change In Valuation Of Investment Securities-3.93
Payment For Contingent Consideration Liability Operating Activities-1.34
Income taxes0.22
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net-0.05
Increase (Decrease) in Accounts Receivable1.58
Increase (Decrease) in Accounts Payable2.60
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-2.27
Other Noncash Income (Expense)-1.84
Other net0.00
Payments for (Proceeds from) Other Operating Activities77.27
Discontinued operations0.00
Net Cash flow from Operating Activities33.35
Investing Activities
Capital Expenditures34.63
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Payment Related To Collaborative Arrangement-
Proceeds From Sale Of Discontinued Operations-
Proceeds From Sale Of Subsidiary-
Net Cash Proceeds From Sale Of Subsidiary-
Contingent Consideration Payments Related To Asset Acquisitions-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Payments to Acquire Additional Interest in Subsidiaries0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.03
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-34.60
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.53
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.93
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.43
Other net-86.17
Repurchase And Retirement Of Common Shares-
Finance Lease Principal Payments-0.76
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations85.74
Contingent Consideration Milestone Payment-4.99
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.79
Effect of exchange rate on cash flow1.41
Discontinued operations0.00
Free Cash Flow67.97
Total Cash Flow-0.62
4 historic quarters locked

Sign in to unlock the full Orthofix Medical Inc cash flow history.

Sign In Create Free Account

About Orthofix Medical Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: ofix-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-065189

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document